Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1989-04-11
1991-03-12
Friedman, Stanley J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514863, 514908, A61K 3135
Patent
active
049993755
ABSTRACT:
Psoralen compositions for extracorporeal administration to blood prior to reinfusion into a subject comprising a sterile aqueous solution of about 0.005 to about 1 mg/ml of a psoralen ethyl alcohol, propylene glycol and water and having a pH from about 2.0 to about 6.0 are disclosed. These compositions are useful for the therapy of a subject being treated by ultraviolet-A photophoresis.
REFERENCES:
patent: 4147703 (1979-04-01), Liebman et al.
patent: 4321919 (1982-03-01), Edelson
patent: 4454152 (1984-06-01), Barry et al.
patent: 4612007 (1986-09-01), Edelson
patent: 4613322 (1986-09-01), Edelson
patent: 4683889 (1987-08-01), Edelson
patent: 4684521 (1987-08-01), Edelson
patent: 4727027 (1988-02-01), Wieseham
patent: 4826967 (1987-06-01), Glass
patent: 4913901 (1990-04-01), Schlager
Edelson, Scientific American, Aug. 1988, p. 68.
Dover et al., Archives of Dermatology, vol. 122:763, (1986).
Sullivan et al., Archives of Dermatology, vol. 112:768 (1986).
Monbaliu, et al., Dermatologica 163:468 (1981).
Edelson, et al., New England Journal of Medicine, 316:297 (1987).
Chemical Abstracts 97:11747c.
Bachynsky Maria O.
Infeld Martin H.
Margolis Richard J.
Perla Dennis A.
Epstein William H.
Friedman Stanley J.
Gould George M.
Hoffmann-La Roche Inc.
Holliden Gary E.
LandOfFree
Psoralen reagent compositions for extracorporeal treatment of bl does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Psoralen reagent compositions for extracorporeal treatment of bl, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Psoralen reagent compositions for extracorporeal treatment of bl will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-448872